International Journal of Women''s Dermatology最新文献

{"title":"Cognitive behavior therapy as dermatological treatment: a narrative review.","authors":"Rishab R Revankar,&nbsp;Nikita R Revankar,&nbsp;Esther A Balogh,&nbsp;Heli A Patel,&nbsp;Sebastian G Kaplan,&nbsp;Steven R Feldman","doi":"10.1097/JW9.0000000000000068","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000068","url":null,"abstract":"<p><p>Cognitive behavior therapy (CBT) is efficacious in treating numerous psychological disorders. It is also effective in combination with medication for chronic pain, diabetes, and other diseases. Patients with skin disease report high levels of stress, anxiety, and negative feelings.</p><p><strong>Objective: </strong>To summarize the findings on the utility of CBT for the improvement of skin status and quality of life in patients with dermatological conditions.</p><p><strong>Methods: </strong>PubMed and Google Scholar databases were searched for relevant articles from database inception to the time of search (October 20, 2021). A total of 30 included studies featured 10 on psoriasis, 11 on atopic dermatitis, 4 on vitiligo, 4 on acne, and 1 study on alopecia areata.</p><p><strong>Results: </strong>Several studies, including randomized controlled trials with large study samples, support the effectiveness of CBT and Internet CBT for a number of dermatological conditions. Patients who completed CBT courses were less likely to rely on dermatological healthcare during follow-up.</p><p><strong>Limitations: </strong>There are a limited number of studies discussing the implementation of CBT for alopecia, acne, and vitiligo.</p><p><strong>Conclusion: </strong>Patients who underwent CBT or Internet CBT in addition to skin care demonstrated improvement with quality of life and severity of skin disease as compared to controls only receiving standard of care treatment.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e068"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/38/jw9-8-e068.PMC9788967.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10856510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine.","authors":"Aaron J Frederiks,&nbsp;Rachael S Foster,&nbsp;Bernadette Ricciardo","doi":"10.1097/JW9.0000000000000066","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000066","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e066"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/82/jw9-8-e066.PMC9746224.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating primary palliative care into hidradenitis suppurativa management.","authors":"Terri Shih,&nbsp;Monica Zell,&nbsp;Daniel Karlin,&nbsp;Devea R De,&nbsp;Jan Smogorzewski,&nbsp;Vivian Y Shi,&nbsp;Jennifer L Hsiao","doi":"10.1097/JW9.0000000000000063","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000063","url":null,"abstract":"<p><p>Hidradenitis suppurativa (HS) is a chronic, often debilitating skin condition that disproportionately impacts women in the United States and other Western nations. Dermatologists should consider incorporating palliative care principles into HS management to optimize care. Primary palliative care principles include utilizing evidence-based frameworks in serious illness communication, acknowledging and addressing physical and psychosocial suffering, recognizing and validating the burden of disease in partners, families, and caregivers, and engaging in collaborative care coordination. Certain patients may also benefit from outpatient, or sometimes inpatient, palliative care specialist collaboration, such as those with refractory HS and superimposed challenging psychosocial dynamics and symptom burden. Through integration of these palliative care domains into HS care, dermatologists can optimize their ability to provide comprehensive and compassionate care for patients suffering with this disease.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e063"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/82/jw9-8-e063.PMC9760599.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alopecia areata incognita: clinical characteristics and use of the Sinclair shedding scale.","authors":"Maya S Collins,&nbsp;Shaheir Ali,&nbsp;Kristen Kelley,&nbsp;Maryanne Makredes Senna","doi":"10.1097/JW9.0000000000000067","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000067","url":null,"abstract":"Introduced in 1987, alopecia areata incognita (AAI), is incredibly difficult to diagnose. It presents as persistent, diffuse hair shedding while patients maintain normal hair density.1,2 We report 4 cases of AAI diagnosed in our specialty alopecia clinic, highlighting aspects of the condition that impart high levels of diagnostic suspicion. A chart review conducted between December 2017 and March 2022 yielded 4 patients with AAI. All patients were Caucasian females, average age of 45.3 years (SD = 10.9), with several years of excess scalp hair shedding. They denied telogen effluvium (TE) triggers or patchy hair loss. Initial differential diagnoses included female pattern hair loss (FPHL) and chronic telogen effluvium. Despite diligent treatment with >6 months oral spironolactone and/or oral low dose minoxidil, patients reported no improvement in shedding. All patients were noted to have a distinctive global appearance: normal density of 5–6-cm length terminal hairs on the top of the scalp and dramatically decreased density of longer terminal hairs distally (Fig. 1). Trichoscopy was unrevealing. AAI patients may develop circular patches of classic alopecia areata, but this was not observed in our initial evaluations.2,3 Scalp biopsies in all 4 patients varied with findings and the respective dermatopathologist favored diagnoses are listed in Table 1. Biopsy findings in AAI are subtle and vary depending on the disease stage.4,5 Histopathology in our patients was insufficient for a definitive diagnosis of alopecia areata incognita. Patients with AAI may collect 350–1000 hairs per day using the modified wash test.6 As the modified wash test is notably time consuming and difficult, we utilized the Sinclair shedding scale (SSS) to assess hair shedding.7 All patients reported >Grade 6 daily shedding on the SSS, representing about 750 hairs per day.7 Given our suspicion for AAI, we added monthly intralesional corticosteroid scalp injections at 5 mg/mL doses across the scalp. Patients did not use adjunct topical corticosteroids. After 2 treatment sessions, all patients reported SSS score improvement to the normal range and increased distal hair density (Fig. 1). One patient developed a few patches of subcentimeter classic alopecia areata that subsequently improved. Several AAI publications emphasize diagnosis based on growth phases and trichoscopy.2,3 We highlight an AAI clinical phenotype and demonstrate utility of the SSS when AAI is suspected. Originally developed to aid diagnosis of FPHL, the SSS is useful in assessing the response to treatment in women with varying hair lengths. Given that our patients had straight hair without improved SSS scores despite adequate treatment of FPHL, the SSS provided critical clinical estimates of shedding without extensive effort from patients or providers. The SSS","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e067"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10856512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study.","authors":"Diana S Kim,&nbsp;Nicole Giannotti,&nbsp;Prerna Salian,&nbsp;Alexa B Kimball,&nbsp;Martina L Porter","doi":"10.1097/JW9.0000000000000027","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000027","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e027"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9d/ec/jw9-8-e027.PMC9771265.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10437334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A solitary asymptomatic patch on the palm.","authors":"Sara B Huff,&nbsp;Alisha N Plotner","doi":"10.1097/JW9.0000000000000062","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000062","url":null,"abstract":"A woman in her mid 60s presented for an asymptomatic pink depressed patch on her left thenar eminence. It had been present for 10 years and gradually enlarged. She denied a history of trauma or other local exposure that could have contributed to the formation of the lesion. Her medical history included arthritis, hypertension, hyperlipidemia, and mallet finger of the right hand. She denied any history of skin cancer. Physical examination was notable for a 3 × 2-cm well-demarcated mildly erythematous patch on her left thenar eminence with a raised scaly border (Fig. 1). A biopsy specimen of the peripheral border was obtained for histopathologic analysis (Fig. 2).","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":" ","pages":"e062"},"PeriodicalIF":0.0,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/aa/jw9-8-e062.PMC9699500.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Painful fissured plaque in a girl with Crohn's disease.","authors":"Meshal M Alhameedy,&nbsp;Areen M Alhemedy","doi":"10.1097/JW9.0000000000000065","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000065","url":null,"abstract":"A 16-year-old Saudi girl diagnosed with Crohn’s disease (CD) when she was 10 years old, receiving infliximab (5 mg/kg IV) every 8 weeks for 2 years, presented with a painful cutaneous eruption in the posterior auricular region for the last 6 months. Examination found hyperkeratotic eroded fissured crusted erythematous plaque in the left posterior auricular area extending to the earlobe (Fig. 1A), progressively increasing over the last 6 months, associated with moderate to severe pain and mild pruritus. Dermatoscopic examination revealed uniform dotted vessels and a white-to-yellowish scale. There was no involvement of the scalp, oral and nasal mucosa, genitalia, or nails. Histopathological analyses (Fig. 1B) were performed. Special stains using Periodic acid-Schiff and Grocott methenamine silver revealed no organisms. However, tissue culture and swab for culture and sensitivity grew methicillin-susceptible Staphylococcus aureus. Basic laboratory panels, including complete blood count, liver and renal function tests, hepatitis B and C and HIV serology, purified protein derivative testing, and chest X-ray, were normal.","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":" ","pages":"e065"},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/06/jw9-8-e065.PMC9678592.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40702400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perspectives of obstetricians/gynecologists on hidradenitis suppurativa care: a survey study.","authors":"Rahul Masson,&nbsp;Terri Shih,&nbsp;Devea R De,&nbsp;Sarah Park,&nbsp;Ram Parvataneni,&nbsp;Aaron Goldberg,&nbsp;Christopher J Sayed,&nbsp;Vivian Y Shi,&nbsp;Jennifer L Hsiao","doi":"10.1097/JW9.0000000000000064","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000064","url":null,"abstract":"Obstetricians-gynecologists (OB-GYNs) are key front-line providers for hidradenitis suppurativa (HS), especially since HS disproportionately affects women of child-bearing age.1 Herein, we explored the perspectives of OB-GYN providers regarding HS care to elicit any knowledge and practice gaps. An anonymous survey was distributed online between May and July 2022 through OB-GYN organizational listservs and in-person at the 2022 Annual American College of OB-GYN Meeting. OB-GYN providers over the age of 18 were eligible to participate. T-tests were used for comparative statistics between provider type and survey responses. A P value of <.05 was considered significant. The study is IRB exempt at the University of California, Los Angeles. Demographics of the 104 respondents are summarized in Table 1. Less than 20% of respondents felt confident managing patients with moderate-severe HS (17/104, 16.3%), discussing how pregnancy/postpartum may affect HS (18/103, 17.5%), or managing HS in pregnancy (20/102, 19.6%) (Fig. 1). Compared to nonphysician providers, physicians were more confident in managing HS during pregnancy (P = .03) and discussing how pregnancy and the postpartum period may affect HS symptoms (P = .046). Attending physicians (11.5 mean years of practice) were more confident than other providers in all queried domains (P < .05). Top treatments prescribed “often”/“sometimes” include oral contraceptives (OCPs) (67.6%, 50/74), topical antibiotics (60.3%, 44/73), oral antibiotics (58.1%, 43/74), and spironolactone (51.4%, 38/74). The majority (91.9%, 68/74) had never prescribed biologics. Procedural treatments were infrequently performed for HS. The majority of respondents “often”/“sometimes” referred patients to dermatology (89.3%, 67/75) and general surgery (46.6%, 34/73), followed by mental health specialists (22.2%, 16/72), HS support groups (19.2%, 14/73), and nutritionists (17.6%, 13/74). Respondents mainly preferred internet-based educational resources (99.0%, 101/102) and peer-reviewed papers (93.1%, 95/102) to learn more about HS. Overall, we found that OB-GYNs were not confident in managing moderate-severe HS, and rarely prescribed biologic agents or performed procedures for HS. This highlights the importance of educating OB-GYNs regarding early referral of patients with HS to dermatologists for appropriate management. Our results show that nearly one-fourth of respondents did not feel confident in diagnosing HS and almost half were not confident in managing mild HS. Important educational areas for OB-GYNs include earlier HS diagnosis, especially given the prevalence of misdiagnosis of HS,2 and management of mild HS. One German study found that approximately 30% of patients had consulted gynecologists for HS symptoms, but only around 5% were ultimately diagnosed by gynecologists.3 An additional high-yield management area to target for OB-GYNs is use of OCPs and spironolactone to help women who have hormone-related HS exacerbations.4 O","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":" ","pages":"e064"},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5f/70/jw9-8-e064.PMC9678498.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40702399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Morbilliform eruption and systemic inflammatory response syndrome following mRNA COVID-19 vaccination in a patient receiving penicillamine.","authors":"James P Pham,&nbsp;Phoebe Star,&nbsp;Annika Smith","doi":"10.1097/JW9.0000000000000058","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000058","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":" ","pages":"e058"},"PeriodicalIF":0.0,"publicationDate":"2022-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ac/fd/jw9-8-e058.PMC9674477.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40506858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil.","authors":"Kelly Z Young,&nbsp;Linna L Guan,&nbsp;Ben J Friedman,&nbsp;Pranita V Rambhatla","doi":"10.1097/JW9.0000000000000061","DOIUrl":"10.1097/JW9.0000000000000061","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":" ","pages":"e061"},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/81/jw9-8-e061.PMC9622688.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40450640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}